A carregar...
Checkpoint inhibitor immunotherapy for glioblastoma: current progress, challenges and future outlook
INTRODUCTION: Despite maximal surgical resection and chemoradiation, glioblastoma (GBM) continues to be associated with significant morbidity and mortality. Novel therapeutic strategies are urgently needed. Given success in treating multiple other forms of cancer, checkpoint inhibitor immunotherapy...
Na minha lista:
| Publicado no: | Expert Rev Clin Pharmacol |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7658017/ https://ncbi.nlm.nih.gov/pubmed/32862726 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17512433.2020.1817737 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|